SCHEMBL4388276

SCHEMBL4388276

Cc1nc2cc3ccccc3cc2[nH]1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.59
LMNA P02545 3/20 0.59
HSD17B10 Q99714 2/20 0.59
RAB9A P51151 8/20 0.58
MAPT P10636 8/20 0.58
SMN1; SMN2 Q16637 7/20 0.58
NPC1 O15118 7/20 0.58
ALDH1A1 P00352 6/20 0.58
HPGD P15428 5/20 0.58
GAA P10253 3/20 0.58
GLA P06280 2/20 0.58
USP2 O75604 1/20 0.58
KMT2A Q03164 5/20 0.56
POLB P06746 5/20 0.56
MEN1 O00255 4/20 0.56
STAT1 P42224 2/20 0.50
HCRTR1 O43613 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30205255 1.00 KDM4E (0.59) KDM4ELMNAHSD17B10RAB9AMAPT
SCHEMBL13947194 0.85 ALDH1A1 (0.53) KDM4ELMNAHSD17B10RAB9AMAPT
SCHEMBL2756728 0.82 ALDH1A1 (0.49) KDM4ELMNAHSD17B10RAB9AMAPT
SCHEMBL14588329 0.82 RAB9A (0.51) KDM4ELMNAHSD17B10RAB9AMAPT
SCHEMBL13041691 0.82 ALDH1A1 (0.59) KDM4EHSD17B10RAB9AMAPTSMN1; SMN2
SCHEMBL12033711 0.80 KDM4E (0.47) KDM4ELMNAHSD17B10RAB9AMAPT
SCHEMBL12213872 0.80 MAPT (0.68) KDM4EHSD17B10RAB9AMAPTSMN1; SMN2
SCHEMBL29339069 0.80 NPC1 (0.46) KDM4ERAB9AMAPTSMN1; SMN2NPC1
SCHEMBL14193952 0.78 NPC1 (0.63) KDM4ELMNAHSD17B10RAB9AMAPT
SCHEMBL11430318 0.77 SMN1; SMN2 (0.54) KDM4ERAB9ASMN1; SMN2NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1976829-A2 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS GENELABS TECHNOLOGIES, INC. (US) 2008-10-08 EP claimed
US-20070265262-A1 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS GENELABS TECHNOLOGIES, INC. 2007-11-15 US claimed
WO-2007070556-A2 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS GENELABS TECHNOLOGIES, INC. (US) 2007-06-21 WO claimed
US-20240239780-A1 MODIFIED FERROPORTIN INHIBITORS VIFOR (INTERNATIONAL) AG (CH) 2024-07-18 US disclosed
US-10323338-B2 Process for making composites comprising rigid-rod polymers and graphene nanoparticles TJC Polymer Inc. (US) 2019-06-18 US disclosed
US-20180105957-A1 PROCESS FOR MAKING COMPOSITES COMPRISING RIGID-ROD POLYMERS AND GRAPHENE NANOPARTICLES DANG THUY D (US) 2018-04-19 US disclosed
US-20180105957-A1 PROCESS FOR MAKING COMPOSITES COMPRISING RIGID-ROD POLYMERS AND GRAPHENE NANOPARTICLES DANG THUY D (US) 2018-04-19 US disclosed
US-9850596-B2 Composites comprising rigid-rod polymers and graphene nanoparticles and process for making the same TJC Polymer Inc. (US) 2017-12-26 US disclosed
US-20160115136-A1 COMPOUNDS, COMPOSITIONS COMPRSING SAME, AND METHODS RELATED THERETO UNIVERSITY OF IOWA RESEARCH FOUNDATION 2016-04-28 US disclosed
US-20150218730-A1 COMPOSITES COMPRISING RIGID-ROD POLYMERS AND GRAPHENE NANOPARTICLES AND PROCESS FOR MAKING THE SAME DANG THUY D (US) 2015-08-06 US disclosed
EP-1706398-B1 Amino-benzazoles as P2Y1 receptor inhibitors BRISTOL MYERS SQUIBB CO (US) 2014-05-21 EP disclosed
US-20080275090-A1 AMINO-BENZAZOLES AS P2Y1 RECEPTOR INHIBITORS WITH PYRIDINE RING AND HETEROCYCLIC COMPONENTS BRISTOL-MYERS SQUIBB COMPANY 2008-11-06 US disclosed
US-20080275090-A1 AMINO-BENZAZOLES AS P2Y1 RECEPTOR INHIBITORS WITH PYRIDINE RING AND HETEROCYCLIC COMPONENTS BRISTOL-MYERS SQUIBB COMPANY 2008-11-06 US disclosed
EP-1976829-A2 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS GENELABS TECHNOLOGIES, INC. (US) 2008-10-08 EP disclosed
US-20070265262-A1 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS GENELABS TECHNOLOGIES, INC. 2007-11-15 US disclosed
WO-2007070556-A2 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS GENELABS TECHNOLOGIES, INC. (US) 2007-06-21 WO disclosed
EP-0734386-B1 PLATELET ACTIVATING FACTOR ANTAGONISTS: IMIDAZOPYRIDINE INDOLES ABBOTT LAB (US) 2002-02-06 EP disclosed
US-5486525-A ANTIINFLAMMATORY AGENTS ABBOTT LABORATORIES (US) 1996-01-23 US disclosed
US-4782050-A BACTERICIDES PFIZER INC. (US) 1988-11-01 US disclosed
EP-0276942-A1 6-Beta(substituted)-(S)-hydroxymethylpenicillanic acids and derivatives thereof PFIZER INC. (US) 1988-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160115136-A1 COMPOUNDS, COMPOSITIONS COMPRSING SAME, AND METHODS RELATED THERETO LPO, NOTUM, FARS2 KDM4E 2304/4885LMNA 1123/4885HSD17B10 1254/4885
US-20070265262-A1 N-(6-MEMBERED AROMATIC RING)-AMIDO ANTI-VIRAL COMPOUNDS ZC3HAV1, HAVCR2, ZC3HAV1L KDM4E 1389/4885LMNA 1290/4885HSD17B10 4303/4885
US-20240239780-A1 MODIFIED FERROPORTIN INHIBITORS SLC40A1, HAMP, TFRC KDM4E 4600/4885LMNA 2374/4885HSD17B10 972/4885
US-20080275090-A1 AMINO-BENZAZOLES AS P2Y1 RECEPTOR INHIBITORS WITH PYRIDINE RING AND HETEROCYCLIC COMPONENTS P2RY1, P2RY11, P2RY2 KDM4E 3857/4885LMNA 4134/4885HSD17B10 4754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.